Controlling Pharmaceutical Risks: Science, Cancer, and the Geneticization of Drug Testing

by John Abraham and Rachel Ballinger

Controlling Pharmaceutical Risks is a case study of changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals. Radically new ways of determining whether medical drugs might cause cancer have been established world-wide since the turn of the century. At the heart of these transformations is the geneticization of drug testing and explanations for cancer induction. The...

• Format: Hardcover
• Language: English
• ISBN: 0415622476
• ISBN13: 9780415622479
• Release Date: June 2025
• Publisher: Routledge
• Length: 224 Pages